For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Although there are many outstanding questions about Alzheimer’s and a significant lack of effective drugs, scientists believe a protein called amyloid-beta plays an important role in the condition.

It’s a lab-made antibody that targets beta amyloid, one of two proteins thought to play a critical role in causing Alzheimer’s (the other being tau). In people with Alzheimer’s, a misfolded ...

That view is informed by data on the first wave of successful anti-amyloid-beta antibodies. Roche is hoping to improve on those molecules by pairing its antibody with technology for crossing the ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...